334 related articles for article (PubMed ID: 28259385)
1. KSHV microRNAs: Tricks of the Devil.
Qin J; Li W; Gao SJ; Lu C
Trends Microbiol; 2017 Aug; 25(8):648-661. PubMed ID: 28259385
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNAs promote matrix metalloproteinases (MMPs) expression and pro-angiogenic cytokine secretion in endothelial cells.
Guo Y; Li W; Qin J; Lu C; Fan W
J Med Virol; 2017 Jul; 89(7):1274-1280. PubMed ID: 28165144
[TBL] [Abstract][Full Text] [Related]
3. miRNAs and their roles in KSHV pathogenesis.
Hussein HAM; Alfhili MA; Pakala P; Simon S; Hussain J; McCubrey JA; Akula SM
Virus Res; 2019 Jun; 266():15-24. PubMed ID: 30951791
[TBL] [Abstract][Full Text] [Related]
4. A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway.
Li W; Jia X; Shen C; Zhang M; Xu J; Shang Y; Zhu K; Hu M; Yan Q; Qin D; Lee MS; Zhu J; Lu H; Krueger BJ; Renne R; Gao SJ; Lu C
Oncotarget; 2016 May; 7(22):32286-305. PubMed ID: 27058419
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells.
Cai X; Lu S; Zhang Z; Gonzalez CM; Damania B; Cullen BR
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5570-5. PubMed ID: 15800047
[TBL] [Abstract][Full Text] [Related]
6. microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus.
Sethuraman S; Gay LA; Jain V; Haecker I; Renne R
PLoS Pathog; 2017 Jul; 13(7):e1006508. PubMed ID: 28715488
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells Hyperresponsive to Secondary Infections.
Sin SH; Eason AB; Bigi R; Kim Y; Kang S; Tan K; Seltzer TA; Venkataramanan R; An H; Dittmer DP
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021906
[TBL] [Abstract][Full Text] [Related]
8. Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection.
Serquiña AKP; Kambach DM; Sarker O; Ziegelbauer JM
mBio; 2017 Jul; 8(4):. PubMed ID: 28698273
[TBL] [Abstract][Full Text] [Related]
9. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
10. Modified Cross-Linking, Ligation, and Sequencing of Hybrids (qCLASH) Identifies Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Targets in Endothelial Cells.
Gay LA; Sethuraman S; Thomas M; Turner PC; Renne R
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386283
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus.
Liang Z; Qin Z; Riker AI; Xi Y
Biochem Biophys Res Commun; 2020 Dec; 533(4):1400-1405. PubMed ID: 33092788
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
Ramalingam D; Happel C; Ziegelbauer JM
J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
Liu X; Happel C; Ziegelbauer JM
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells.
Yogev O; Lagos D; Enver T; Boshoff C
PLoS Pathog; 2014 Sep; 10(9):e1004400. PubMed ID: 25255370
[TBL] [Abstract][Full Text] [Related]
16. Cellular MicroRNA Let-7a Suppresses KSHV Replication through Targeting MAP4K4 Signaling Pathways.
Tan X; Gao Y; Nan Y; Zhang J; Di C; Wang X; Lian F; Cao Y; Hu Y; Xu L; Ma H; Hong Y; Liu T; Wu Y; Xu X; Yan Y; Yang L
PLoS One; 2015; 10(7):e0132148. PubMed ID: 26197270
[TBL] [Abstract][Full Text] [Related]
17. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.
Haecker I; Gay LA; Yang Y; Hu J; Morse AM; McIntyre LM; Renne R
PLoS Pathog; 2012; 8(8):e1002884. PubMed ID: 22927820
[TBL] [Abstract][Full Text] [Related]
18. KSHV-Mediated Angiogenesis in Tumor Progression.
Purushothaman P; Uppal T; Sarkar R; Verma SC
Viruses; 2016 Jul; 8(7):. PubMed ID: 27447661
[TBL] [Abstract][Full Text] [Related]
19. The Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Encodes a Mimic of the Tumor-Suppressive miR-15/16 miRNA Family.
Morrison K; Manzano M; Chung K; Schipma MJ; Bartom ET; Gottwein E
Cell Rep; 2019 Dec; 29(10):2961-2969.e6. PubMed ID: 31801064
[TBL] [Abstract][Full Text] [Related]
20. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
J Virol; 2017 May; 91(10):. PubMed ID: 28275189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]